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Cardiovascular diseases, particular those related to atherosclerosis and hypertension, are often perceived to be 
problems unique to the “developed world”. However, in many regions of the world, active lives have been 
reduced to inactive ones with people consuming calories out of proportion to daily needs. New ways of 
processing food promote obesity and are a cause of the atherogenic load causing disease.
The use of technology in the form of novel drugs and devices, as well as surgical procedures, mitigates some of 
the consequences of this unhealthy life-style, albeit with the overall effect of palliation rather than cure. However, 
it is the repeated observation that vast differences in the amount of investment in health-care technology does 
not translate readily into measurable impact on public health statistics. Over the past decade, the global nature of 
many health problems has become much more evident, meaning that countries across the globe have started to 
adopt similar life styles, and with them a massive increase in cardiovascular risk factors. However, regions such as 
Africa are not prepared for this and need to fi nd their own solutions for addressing this emerging epidemic. 
Treatment and prevention strategies will need to be adjusted for the region and the resource level. Current 
AHA/ACC/ ESC guidelines do not take into account the affordability of the treatment they recommend. However, 
pretending fi scal limitations are not real does very little to advance the effi cient use of available resources based 
on evidence for a particular region.  During the World Congress of Cardiology meeting in Barcelona, the Virtual 
Coordinating Centre for Global Collaborative Cardiovascular Research (VIGOUR) group held a symposium 
examining potential approaches to understanding and controlling the explosive worldwide growth of cardiovascular 
disease and its attendant morbidity and mortality (Mark DB et al.). The necessary action identifi ed focused on 
major areas such as (i) the development of high quality data resources that can be used to study and improve the 
processes, treatment and outcome of CVD globally; (ii) the feasibility and resource/health economic implications; 
(iii) models /systems must be identifi ed that can be used to guide effective interventions targeting health problems 
at an affordable price; (iv) academic research organizations need to assume a more active role in the health-care 
system, both through research and by developing evidence-based medicine along with translation of research 
fi ndings into effective interventions that improve public health.   
This special issue of SA heart is thus dedicated to a giving a glimpse into some of the cardiovascular research 
done in South Africa at present. Some of the articles refer to topics presented at the “Heart 2 Heart” meeting 
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and others to projects performed under the auspices of professional societies such as the Heart Failure Society 
of South Africa (HeFSSA).  
Lee at al. presents data from more than 800 ECGs collected in 2006 from patients presenting with heart failure 
as part of the “Heart of Soweto study” aiming to use a tool that is inexpensive and accessible for screening and 
management.
The next article by Moolman et al. covers diagnostic aspects of more advanced rheumatic heart disease using a 
novel tool: measuring serum levels of natriuretic peptides (BNP and NT-proBNP). 
Postpartum Cardiomyopathy (PPCM) is a common disease in South Africa and exposes women to high risk of 
mortality after delivery despite optimal medical therapy. In this issue Forster et al. summarize data from a 
collaborative project of the University of the Witwatersrand and Hannover University, Germany demonstrating 
that enhanced oxidative stress promotes the proteolytical processing of the nursing hormone prolactin into a 
biologically active derivative, the 16kDa prolactin, which appears to be a major cause for PPCM.  This implies that 
inhibition of prolactin release with bromocryptine may represent a novel therapeutic strategy and in fact early 
clinical fi ndings are supportive of this specifi c novel therapy for PPCM.
Dr Shirley Middlemost provides an excellent review on depression, a common problem in cardiac patients that 
is commonly ignored or not well managed by physicians and cardiologists. This article forms part of a new series, 
“Life with Chronic Heart Failure”, initiated by the South African Heart Failure Society (HeFSSA).  
I hope to see many more relevant simple or complex research projects investigating common cardiovascular 
conditions in Africa being published in the near future.
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